Chapter 12 : Autoimmunity in Lyme Arthritis: Molecular Mimicry between OspA and LFA-1

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in

Autoimmunity in Lyme Arthritis: Molecular Mimicry between OspA and LFA-1, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818074/9781555811945_Chap12-1.gif /docserver/preview/fulltext/10.1128/9781555818074/9781555811945_Chap12-2.gif


The first indication that autoimmunity might play a role in treatment-resistant Lyme arthritis was a study of HLA-allele association with Lyme arthritis. The risk for development of treatment-resistant Lyme arthritis has been shown to double when patients have the HLA-DR4 specificity and generate an anti-outer surface protein A (OspA) antibody response. Immunodeficient severe combined immunodeficient (SCID) mice infected with develop severe arthritis, carditis, and hepatitis, which are preventable if anti-OspA antibodies are administered prior to infection and which are treatable if antibodies are administered after induction of arthritis. The authors' work has explored the population of active cells involved in the propagation of treatment-resistant Lyme arthritis. It had been previously shown that Th1 cells dominate the immune response in the synovial fluid of patients with Lyme arthritis, as well as those with RA or other types of chronic inflammatory arthritis. T-cell lines from patients with treatment-resistant Lyme arthritis have previously been shown to preferentially recognize OspA in comparison with T-cell lines from patients with treatment-responsive disease. The authors suggest that OspA, in the context of DR4-homologous alleles, triggers development of an autoimmune response to human lymphocyte function-associated antigen 1 (hLFA-1), which leads to treatment-resistant Lyme arthritis. That is, if the spirochetal infection is prevented from disseminating into the joint or is eradicated before a strong proinflammatory response can develop in the localized space of the synovial fluid, the vicious cycle of chronic inflammation is prevented before molecular mimicry and autoimmunity can develop.

Citation: Gross D, Huber B. 2000. Autoimmunity in Lyme Arthritis: Molecular Mimicry between OspA and LFA-1, p 161-173. In Cunningham M, Fujinami R (ed), Molecular Mimicry, Microbes, and Autoimmunity. ASM Press, Washington, DC. doi: 10.1128/9781555818074.ch12
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


Image of Figure 1
Figure 1

Model of how autoimmunity develops in patients with treatment-resistant Lyme arthritis. migrates to the joint and induces a localized Th1-dominant response with OspA specificity. The unbalanced production of IFN-γ induces upregulation of MHC class II on both classical and atypical APCs. Furthermore, LFA-1 expression becomes enhanced on T cells, as well as macrophages, as does ICAM-1 expression due to the presence of IFN-γ and itself. This results in processing and presentation of LFA-1, which leads to activation of OspA-primed T cells, even in the absence of .

Citation: Gross D, Huber B. 2000. Autoimmunity in Lyme Arthritis: Molecular Mimicry between OspA and LFA-1, p 161-173. In Cunningham M, Fujinami R (ed), Molecular Mimicry, Microbes, and Autoimmunity. ASM Press, Washington, DC. doi: 10.1128/9781555818074.ch12
Permissions and Reprints Request Permissions
Download as Powerpoint


1. Appel, M. J.,, S. Allan,, R. H. Jacobson,, T. L. Lauderdale,, Y. F. Chang,, S. J. Shin,, J. W. Thomford,, R. J. Todhunter,, and B. A. Summers. 1993. Experimental Lyme disease in dogs produces arthritis and persistent infection. J. Infect. Dis. 167: 651 664.
2. Barthold, S.,, D. S. Beck,, G. M. Hansen,, G. A. Terwilliger,, and K. D. Moody. 1990. Lyme borreliosis in selected strains and ages of laboratory mice. J. Infect. Dis. 162: 133 138.
3. Barthold, S. W.,, M. S. de Souza,, J. L. Janotka,, A. L. Smith,, and D. H. Persing. 1993. Chronic Lyme borreliosis in the laboratory mouse. Am. J. Pathol. 143: 959 971.
4. Barthold, S. W.,, M. deSouza,, and S. Feng. 1996. Serum-mediated resolution of Lyme arthritis in mice. Lab. Investig. 74: 57 67.
5. Barthold, S. W.,, E. Fikrig,, L. K. Bockenstedt,, and D. H. Persing. 1995. Circumvention of outer surface protein A immunity by host-adapted Borrelia burgdorferi. Infect. Immun. 63: 2255 2261.
6. Barthold, S. W.,, K. D. Moody,, and D. S. Beck. 1990. Susceptibility of laboratory rats to isolates of Borrelia burgdorferi from different geographic areas, Am. J. Trop. Med. Hyg. 42: 596 600.
7. Bockenstedt, L. K.,, S. Barthold,, K. Deponte,, N. Marcantonio,, and F. Kantor. 1993. Borrelia burgdorferi infection and immunity in mice deficient in the fifth component of complement. Infect. Immun. 61: 2104 2107.
8. Bockenstedt, L. K.,, E. Fikrig,, S. W. Barthold,, R. A. Flavell,, and F. S. Kantor. 1996. Identification of a Borrelia burgdorferi OspA T cell epitope that promotes anti-OspA IgG in mice. J. Immunol. 157: 5496 5502.
9. Boggemeyer, E.,, T. Stehle,, U. E. Schaible,, M. Hahne,, D. Vestweber,, and M. M. Simon. 1994. Borrelia burgdorferi upregulates the adhesion molecules E-selectin, P-selectin, ICAM-1 and VCAM-1 on mouse endothelioma cells in vitro. Cell Adhesion Commun. 2: 145 157.
10. Bottomly, K. 1988. A functional dichotomy in CD4 + T lymphocytes. Immunol. Today 9: 268 274.
11. Bradley, J. F.,, R. C. Johnson,, and J. L. Goodman. 1994. The persistence of spirochetal nucleic acids in active Lyme arthritis. Ann. Intern. Med. 120: 487 489.
12. Breitschwerdt, E. B.,, F. J. Geoly,, D. J. Meuten,, J. F. Levine,, P. Howard,, B. C. Hegarty,, and L. C. Stafford. 1996. Myocarditis in mice and guinea pigs experimentally infected with a canine-origin Borrelia isolate from Florida. Am. J. Vet. Res. 57: 505 511.
13. Cherwinski, H. M.,, J. H. Schumacher,, K. D. Brown,, and T. R. Mosmann. 1987. Two types of mouse helper T cell clone, III. Further differences in lymphokine synthesis between Thl and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J. Exp. Med. 166: 1229 1244.
14. Cohen, I. R. 1992. The cognitive paradigm and the immunological homunculus. Immunol. Today 13: 490 494.
15. Cohen, I. R. 1992. The cognitive principle challenges clonal selection. Immunol. Today 13: 441 444.
16. Corcoran, M. L.,, W. G. Stetler-Stevenson,, P. D. Brown,, and L. M. Wahl. 1992. Interleukin 4 inhibition of prostaglandin E2 synthesis blocks interstitial collagenase and 92-kDa type IV collagenase/gelatinase production by human monocytes. J. Biol. Chem. 267: 515 519.
17. Davignon, D.,, E. Martz,, T. Reynolds,, K. Kurainger,, and T. A. Springer. 1981. Monoclonal antibody to a novel lymphocyte function associated antigen (LFA-1): mechanism of blockade of T lymphocyte-mediated killing and effects on the T and B lymphocyte functions. J. Immunol. 127: 590 595.
18. de Souza, M. S.,, A. L. Smith,, D. S. Beck,, G. A. Terwilliger,, E. Fikrig,, and S. W. Barthold. 1993. Long-term study of cell-mediated responses to Borrelia burgdorferi in the laboratory mouse. Infect. Immun. 61: 1814 1822.
19. Dessen, A.,, C. M. Lawrence,, S. Cupo,, D. M. Zaller,, and D. C. Wiley. 1997. X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II. Immunity 7: 473 481.
20. Dustin, M. L.,, R. Rothlein,, A. K. Bhan,, C. A. Dinarello,, and T. A. Springer. 1986. Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol. 137: 245 254.
21. Ebnet, K.,, K. D. Brown,, U. K. Siebenlist,, M. M. Simon,, and S. Shaw. 1997. Borrelia burgdorferi activates nuclear factor-kappa B and is a potent inducer of chemokine and adhesion molecule gene expression in endothelial cells and fibroblasts. J. Immunol. 158: 3285 3292.
22. Feng, S.,, S. W. Barthold,, L. K. Bockenstedt,, D. M. Zaller,, and E. Fikrig. 1995. Lyme disease in human DR4Dw4-transgenic mice. J. Infect. Dis. 172: 286 289.
23. Fikrig, E.,, H. Tao,, M. Chen,, S. W. Barthold,, and R. A. Flavell. 1995. Lyme borreliosis in transgenic mice tolerant to B. burgdorferi OspA or B. J. Clin. Investig. 96: 1706 1714.
24. Golde, W. T.,, T. R. Burkot,, S. Sviat,, M. G. Keen,, L. W. Mayer,, B. J. Johnson,, and J. Piesman. 1993. The major histocompatibility complex-restricted response of recombinant inbred strains of mice to natural tick transmission of Borrelia burgdorferi. J. Exp. Med. 177: 9 17.
25. Gregersen, P. K.,, J. Silver,, and R. J. Winchester. 1987. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 30: 1205 1213.
26. Gross, D. M.,, A. C. Steere,, and B. T. Huber. 1998. T helper 1 response is dominant and localized to the synovial fluid in patients with Lyme arthritis. J. Immunol. 160: 1022 1028.
27. Gross, D. M.,, T. Forsthuber,, M. Tary-Lehmann,, C. Etling,, K. Ito,, Z. Najy,, J. Field,, A. C. Steere,, and B. T. Huber. 1998. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science 281: 703 706.
28. Hammer, J.,, F. Gallazzi,, E. Bono,, R. W. Karr,, J. Guenot,, P. Valsasnini,, Z. A. Nagy,, and F. Sinigaglia. 1995. Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J. Exp. Med. 181: 1847 1855.
29. Hammer, J.,, P. Valsasnini,, K. Tolba,, D. Bolin,, J. Higelin,, B. Takacs,, and F. Sinigaglia. 1993. Promiscuous and allele-specific anchors in HLA-DR-binding peptides. Cell 74: 197 203.
30. Heinzel, F. P.,, M. D. Sadick,, S. S. Mutha,, and R. M. Locksley. 1991. Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4 + lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc. Natl. Acad. Sci. USA 88: 7011 7015.
31. Henninger, D. D.,, J. Panes,, M. Eppihimer,, J. Russell,, M. Gerritsen,, D. C. Anderson,, and D. N. Granger. 1997. Cytokine-induced VCAM-1 and ICAM-1 expression in different organs of the mouse. J. Immunol. 158: 1825 1832.
32. Hsieh, C. S.,, S. E. Macatonia,, A. O'Garra,, and K. M. Murphy. 1995. T cell genetic background determines default T helper phenotype development in vitro. J. Exp. Med. 181: 713 721.
33. Ishii, N.,, E. Isogai,, H. Isogai,, K. Kimura,, T. Nishikawa,, N. Fijii,, and H. Nakajima. 1995. T cell response to Borrelia garinii, Borrelia afzelii, and Borrelia japonica in various congenic mouse strains. Microbiol. Immunol. 39: 929 935.
34. Ito, K.,, H. J. Bian,, M. Molina,, J. Han,, J. Magram,, E. Saar,, C. Belunis,, D. R. Bolin,, R. Arceo,, R. Campbell,, F. Falcioni,, D. Vidovic,, J. Hammer,, and Z. A. Nagy. 1996. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis. J. Exp. Med. 183: 2635 2644.
35. Kalish, R. A.,, J. M. Leong,, and A. C. Steere. 1993. Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect. Immun. 61: 2774 2779.
36. Kalish, R. A.,, J. M. Leong,, and A. C. Steere. 1995. Early and late antibody responses to full-length and truncated constructs of outer surface protein A of Borrelia burgdorferi in Lyme disease. Infect. Immun. 63: 2228 2235.
37. Kamradt, T.,, B. Lengl-Janssen,, A. F. Strauss,, G. Bansal,, and A. C. Steere. 1996. Dominant recognition of a Borrelia burgdorferi outer surface protein A peptide by T helper cells in patients with treatment-resistant Lyme arthritis. Infect. Immun. 64: 1284 1289.
38. Keane-Myers, A.,, and S. P. Nickell. 1995. Role of IL-4 and IFN-gamma in modulation of immunity to Borrelia burgdorferi in mice. J. Immunol. 155: 2020 2028.
39. Kornblatt, A. N.,, A. C. Steere,, and D. G. Brownstein. 1984. Experimental Lyme disease in rabbits: spirochetes found in erythema migrans and blood. Infect. Immun. 46: 220 223.
40. Larson, R. S.,, and T. A. Springer. 1990. Structure and function of leukocyte integrins. Immunol. Rev. 114: 181 217.
41. Lim, L. C.,, D. M. England,, B. K. DuChateau,, N. J. Glowacki,, and R. F. Schell. 1995. Borrelia burgdorferi-specific T lymphocytes induce severe destructive Lyme arthritis. Infect. Immun. 63: 1400 1408.
42. Marlin, S. D.,, and T. A. Springer. 1987. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell 51: 813 819.
43. Matyniak, J. E.,, and S. L. Reiner. 1995. T helper phenotype and genetic susceptibility in experimental Lyme disease. J. Exp. Med. 181: 1251 1254.
44. Montgomery, R. R.,, S. E. Malawista,, K. J. Feen,, and L. K. Bockenstedt. 1996. Direct demonstration of antigenic substitution of Borrelia burgdorferi ex vivo: exploration of the paradox of the early immune response to outer surface proteins A and C in Lyme disease. J. Exp. Med. 183: 261 269.
45. Moody, K. D.,, S. W. Barthold,, and G. A. Terwilliger. 1990. Lyme borreliosis in laboratory animals: effect of host species and in vitro passage of Borrelia burgdorferi. Am. J. Trop. Med. Hyg. 43: 87 92.
46. Moreno, J.,, D. A. Vignali,, F. Nadimi,, S. Fuchs,, L. Adorini,, and G. J. Hammerling. 1991. Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from those derived from exogenous antigen. J. Immunol. 147: 3306 3313.
47. Mosmann, T. R.,, H. Cherwinski,, M. W. Bond,, M. A. Giedlin,, and R. L. Coffman. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136: 2348 2357.
48. Mosmann, T.R.,, and R. L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7: 145 173.
49. Nepom, G. T. 1989. Determinants of genetic susceptibility in HLA-associated autoimmune disease. Clin. Immunol. Immunopathol. 53: S53 S62.
50. Nepom, G. T.,, and H. Erlich. 1991. MHC class-II molecules and autoimmunity. Annu. Rev. Immunol. 9: 493 525.
51. Nocton, J. J.,, F. Dressier,, B. J. Rutledge,, P. N. Rys,, D. H. Persing,, and A. C. Steere. 1994. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N. Engl. J. Med. 330: 229 234.
52. Nygard, N. R.,, D. M. McCarthy,, J. Schiffenbauer,, and B. D. Schwartz. 1993. Mixed haplotypes and autoimmunity. Immunol. Today 14: 53 56.
53. Philipp, M. T.,, M. K. Aydintug,, R. P. Bohm Jr.,, F. B. Cogswell,, V. A. Dennis,, H. N. Lanners,, R. C. Lowrie Jr.,, E. D. Roberts,, M. D. Conway,, M. Karacorlu,, G. A. Peyman,, D. J. Gubler,, B. J. B. Johnson,, J. Piesman,, and Y. Gu. 1993. Early and early disseminated phases of Lyme disease in the rhesus monkey: a model for infection in humans. Infect. Immun. 61: 3047 3059.
54. Salemi, S.,, A. P. Caporossi,, L. Boffa,, M. G. Longobardi,, and V. Barnaba. 1995. HIVgpl20 activates autoreactive CD4-specific T cell responses by unveiling of hidden CD4 peptides during processing. J. Exp. Med. 181: 2253 2257.
55. Schaible, U. E.,, S. Gay,, C. Museteanu,, M. D. Kramer,, G. Zimmer,, K. Eichmann,, U. Museteanu,, and M. M. Simon. 1990. Lyme borreliosis in the severe combined immunodeficiency (scid) mouse manifests predominantly in the joints, heart, and liver. Am. J. Pathol. 137: 811 820.
56. Schaible, U. E.,, M. D. Kramer,, K. Eichmann,, M. Modolell,, C. Museteanu,, and M. M. Simon. 1990. Monoclonal antibodies specific for the outer surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (scid) mice. Proc. Natl. Acad. Sci. USA 87: 3768 3772.
57. Schaible, U. E.,, M. D. Kramer,, C. W. Justus,, C. Museteanu,, and M. M. Simon. 1989. Demonstration of antigen-specific T cells and histopathological alterations in mice experimentally inoculated with Borrelia burgdorferi. Infect. Immun. 57: 41 47.
58. Schaible, U. E.,, M. D. Kramer,, C. Museteanu,, G. Zimmer,, H. Mossmann,, and M. M. Simon. 1989. The severe combined immunodeficiency (scid) mouse. A laboratory model for the analysis of Lyme arthritis and carditis. J. Exp. Med. 170: 1427 1432.
59. Schaible, U. E.,, M. D. Kramer,, R. Wallich,, T. Iran,, and M. M. Simon. 1991. Experimental Borrelia burgdorferi infection in inbred mouse strains: antibody response and association of H-2 genes with resistance and susceptibility to development of arthritis. Eur. J. Immunol. 21: 2397 2405.
60. Schaible, U. E.,, D. Vestweber,, E. G. Butcher,, T. Stehle,, and M. M. Simon. 1994. Expression of endothelial cell adhesion molecules in joints and heart during Borrelia burgdorferi infection of mice. Cell Adhesion Commun. 2: 465 479. ( Erratum, 3:178,1995.)
61. Schwartz, B. D. 1990. Infectious agents, immunity, and rheumatic diseases. Arthritis Rheum. 33: 457 465.
62. Scott, P.,, and S. H. Kaufmann. 1991. The role of T-cell subsets and cytokines in the regulation of infection. Immunol. Today 12: 346 348.
63. Sellati, T. J.,, M. J. Burns,, M. A. Ficazzola,, and M. B. Furie. 1995. Borrelia burgdorferi upregulates expression of adhesion molecules on endothelial cells and promotes transendothelial migration of neutrophils in vitro. Infect. Immun. 63: 4439 4447.
64. Shanafelt, M. C.,, J. Anzola,, C. Soderberg,, H. Yssel,, C. W. Turck,, and G. Peltz. 1992. Epitopes on the outer surface protein A of Borrelia burgdorferi recognized by antibodies and T cells of patients with Lyme disease. J. Immunol. 148: 218 224.
65. Sher, A.,, and R. L. Coffman. 1992. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu. Rev. Immunol. 10: 385 409.
66. Simon, M.,, U. E. Schaible,, R. Wallich,, and M. D. Kramer. 1991. A mouse model for Borrelia burgdorferi infection: approach to a vaccine against Lyme disease. Immunol. Today 12: 11 16.
67. Steere, A. C.,, E. Dwyer,, and R. Winchester. 1990. Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles. N. Engl. J. Med. 323: 219 223. ( Erratum, 324:129, 1991.)
68. Steere, A. C.,, A. Gibofsky,, M. E. Patarroyo,, R. J. Winchester,, J. A. Hardin,, and S. E. Malawista. 1979. Chronic Lyme arthritis. Clinical and immunogenetic differentiation from rheumatoid arthritis. Ann. Intern. Med. 90: 896 901.
69. Steere, A. C.,, R. T. Schoen,, and E. Taylor. 1987. The clinical evolution of Lyme arthritis. Ann. Intern. Med. 107: 725 731.
70. Vincent, M. S.,, K. Roessner,, D. Lynch,, D. Wilson,, S. M. Cooper,, J. Tschopp,, L. H. Sigal,, and R. C. Budd. 1996. Apoptosis of Fashigh CD4 + synovial T cells by borrelia-reactive Fas-ligand(high) gamma delta T cells in Lyme arthritis. J. Exp. Med. 184: 2109 2117.
71. Yamamura, M.,, K. Uyemura,, R. J. Deans,, K. Weinberg,, T. H. Rea,, B. R. Bloom,, and R. L. Modlin. 1991. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254: 277 279. ( Erratum, 255:12, 1992.)
72. Yang, L.,, J. H. Weis,, E. Eichwald,, C. P. Kolbert,, D. H. Persing,, and J. J. Weis. 1994. Heritable susceptibility to severe Borrelia burgdorferi-induced arthritis is dominant and is associated with persistence of large numbers of spirochetes in tissues. Infect. Immun. 62: 492 500.
73. Yokota, A.,, N. Murata,, O. Saiki,, M. Shimizu,, T. A. Springer,, and T. Kishimoto. 1995. High avidity state of leukocyte function-associated antigen-1 on rheumatoid synovial fluid T lymphocytes. J. Immunol. 155: 4118 4124.
74. Yssel, H.,, M. C. Shanafelt,, C. Soderberg,, P. V. Schneider,, J. Anzola,, and G. Peltz. 1991. Borrelia burgdorferi activates a T helper type 1-like T cell subset in Lyme arthritis. J. Exp. Med. 174: 593 601.
75. Zhao, Z. S.,, F. Granucci,, L. Yeh,, P. A. Schaffer,, and H. Cantor. 1998. Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science 279: 1344 1347.
76. Zhong, W.,, K. H. Wiesmuller,, M. D. Kramer,, R. Wallich,, and M. M. Simon. 1996. Plasmid DNA and protein vaccination of mice to the outer surface protein A of Borrelia burgdorferi leads to induction of T helper cells with specificity for a major epitope and augmentation of protective IgG antibodies in vivo. Eur. J. Immunol. 26: 2749 2757.


Generic image for table
Table 1

DR molecules with peptide-binding cleft residues homologous to DRB1*0401

Citation: Gross D, Huber B. 2000. Autoimmunity in Lyme Arthritis: Molecular Mimicry between OspA and LFA-1, p 161-173. In Cunningham M, Fujinami R (ed), Molecular Mimicry, Microbes, and Autoimmunity. ASM Press, Washington, DC. doi: 10.1128/9781555818074.ch12
Generic image for table
Table 2

OspA and hLFA-1α are not predicted to bind to DRB1*0402

Citation: Gross D, Huber B. 2000. Autoimmunity in Lyme Arthritis: Molecular Mimicry between OspA and LFA-1, p 161-173. In Cunningham M, Fujinami R (ed), Molecular Mimicry, Microbes, and Autoimmunity. ASM Press, Washington, DC. doi: 10.1128/9781555818074.ch12

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error